Celgene Corp
CELG
CELG was delisted on the 20th of November, 2019.
1,470 hedge funds and large institutions have $61.8B invested in Celgene Corp in 2017 Q4 according to their latest regulatory filings, with 207 funds opening new positions, 536 increasing their positions, 607 reducing their positions, and 208 closing their positions.
0% less first-time investments, than exits
New positions opened: 207 | Existing positions closed: 208
1% less funds holding
Funds holding: 1,484 → 1,470 (-14)
6.05% less ownership
Funds ownership: 81.24% → 75.19% (-6.1%)
12% less repeat investments, than reductions
Existing positions increased: 536 | Existing positions reduced: 607
29% less call options, than puts
Call options by funds: $1.27B | Put options by funds: $1.78B
33% less capital invested
Capital invested by funds: $92.1B → $61.8B (-$30.3B)
63% less funds holding in top 10
Funds holding in top 10: 150 → 55 (-95)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$418M |
| 2 |
Two Sigma Advisers
New York
|
+$277M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$268M |
| 4 |
Goldman Sachs
New York
|
+$242M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$154M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$581M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$557M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$544M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$510M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$494M |
CELG Hedge Fund Activity: Q4 2017 in Review
1,470 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Celgene Corp (CELG) for Q4 2017, worth a combined $61.8B — down 33% from $92.1B a quarter earlier.
Sellers outnumbered buyers: 208 funds closed out of CELG and 207 opened new positions — a net loss of 1 holder — while 607 trimmed existing stakes and 536 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $418M. The largest seller was Jennison Associates, cutting an estimated $581M.
- 1,470 institutional investors held Celgene Corp (CELG) as of Q4 2017, down from 1,484 in Q3 2017.
- Funds reported $61.8B of Celgene Corp stock for Q4 2017, down 33% quarter-over-quarter.
- 207 funds opened new Celgene Corp positions in Q4 2017 and 208 closed out, a net change of -1 holder.
- The largest Celgene Corp buyer in Q4 2017 was Citadel Advisors, an estimated $418M added.
- The largest Celgene Corp seller in Q4 2017 was Jennison Associates, an estimated $581M sold.
Based on aggregated 13F filings for Q4 2017.